ASB Consultores LLC Cuts Holdings in The Cigna Group (NYSE:CI)

ASB Consultores LLC lessened its stake in The Cigna Group (NYSE:CI) by 18.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,176 shares of the health services provider’s stock after selling 268 shares during the quarter. ASB Consultores LLC’s holdings in The Cigna Group were worth $407,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in CI. Norden Group LLC grew its stake in shares of The Cigna Group by 22.3% during the first quarter. Norden Group LLC now owns 2,355 shares of the health services provider’s stock worth $855,000 after purchasing an additional 429 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in shares of The Cigna Group by 3.6% during the 1st quarter. Janney Montgomery Scott LLC now owns 30,151 shares of the health services provider’s stock worth $10,951,000 after acquiring an additional 1,037 shares in the last quarter. Choreo LLC increased its holdings in shares of The Cigna Group by 54.6% in the 1st quarter. Choreo LLC now owns 1,623 shares of the health services provider’s stock valued at $590,000 after acquiring an additional 573 shares during the last quarter. Financial Counselors Inc. raised its position in shares of The Cigna Group by 2.2% during the 1st quarter. Financial Counselors Inc. now owns 1,748 shares of the health services provider’s stock worth $635,000 after acquiring an additional 38 shares in the last quarter. Finally, Rehmann Capital Advisory Group acquired a new stake in shares of The Cigna Group during the 1st quarter worth about $268,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity at The Cigna Group

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the transaction, the director now owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.70% of the stock is owned by insiders.

The Cigna Group Price Performance

Shares of CI opened at $312.32 on Tuesday. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $370.83. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The firm has a market cap of $86.87 billion, a price-to-earnings ratio of 29.46, a PEG ratio of 0.96 and a beta of 0.51. The stock has a 50 day moving average of $344.94 and a 200-day moving average of $341.23.

The Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping the consensus estimate of $7.22 by $0.29. The firm had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The Cigna Group’s quarterly revenue was up 29.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.77 earnings per share. As a group, analysts forecast that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.79%. The Cigna Group’s dividend payout ratio (DPR) is presently 52.83%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CI. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday. JPMorgan Chase & Co. upped their price objective on shares of The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. Barclays lifted their target price on The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Royal Bank of Canada decreased their target price on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research report on Friday. Finally, Stephens reaffirmed an “overweight” rating and set a $410.00 price target on shares of The Cigna Group in a research report on Friday. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, The Cigna Group currently has an average rating of “Buy” and an average target price of $394.00.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.